Many patients taking GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound) report altered taste experiences during treatment
Citing limitations in the study, Novo Nordisk, which makes the drugs included in the claims analysis, said in a statement reported by Reuters that it does not believe these data are sufficient to draw conclusions about overall patient adherence and persistence to various GLP-1 medicines, including our treatments. Nonetheless, the problem of lack of patient persistence on GLP-1s under real-world conditions, examined and published by a growing number of sources, isnt going away
Meanwhile, the study can also provide drug selection recommendations and methodological references for healthcare organizations in other countries, especially in other countries with low and middle incomes or a low level of healthcare
Case report images show some people taking semaglutide have a furry-like or coated appearance to their tongue
Nurses This activity awards 1.50 Nursing contact hours
Hammoud R et al